共 24 条
[1]
Campbell J.K., Penzien D.B., Wall E.M., Evidence-based guidelines for migraine headache: Behavioral and physical treatments, (2000)
[2]
Welch K.M., Contemporary concepts of migraine pathogenesis, Neurology, 61, SUPPL. 4, (2003)
[3]
Kang Y.J., Eisenach J.C., Intrathecal clonidine reduces hypersensitivity after nerve injury by a mechanism involving spinal m4 muscarinic receptors, Anesth. Analg., 96, pp. 1403-1408, (2003)
[4]
Silberstein S.D., Goadsby P.J., Migraine: Preventive treatment, Cephalalgia, 22, pp. 491-512, (2002)
[5]
Ramadan N.M., Schultz L.L., Gilkey S.J., Migraine prophylactic drugs: Proof of efficacy, utilization, and cost, Cephalaigia, 17, pp. 73-80, (1997)
[6]
Ramadan N.M., Silberstein S.D., Freitag F.G., Et al., Evidence-based guidelines for migraine headache in the primary care setting: Pharmacological management for prevention of migraine, (2000)
[7]
Freitag F.G., Collins S.D., Carlson H.A., Et al., A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis, Neurology, 58, pp. 1652-1659, (2002)
[8]
Edwards K.R., Potter D.L., Wit S.C., Et al., Topiramate in the preventive treatment of episodic migraine: A combined analysis from pilot, double-blind, placebo-controlled trials, CNS Spectr., 8, pp. 428-432, (2003)
[9]
Mathew N.T., Rapoport A., Saper J., Et al., Efficacy of gabapentin in migraine prophylaxis, Headache, 41, pp. 119-128, (2001)
[10]
Cutter F.M., Limmroth V., Moskowitz M.A., Possible mechanisms of valproate in migraine prophylaxis, Cephalalgia, 17, pp. 93-100, (1997)

